Risks associated with the therapeutic use of fluoroquinolones

@article{Stahlmann2013RisksAW,
  title={Risks associated with the therapeutic use of fluoroquinolones},
  author={Ralf Stahlmann and Hartmut M. Lode},
  journal={Expert Opinion on Drug Safety},
  year={2013},
  volume={12},
  pages={497 - 505}
}
Introduction: Quinolones are among the most often prescribed antimicrobial agents. Some types of toxicity observed during therapy with these drugs have gained much attention. Areas covered: Here, we review the potential of the most widely used fluoroquinolones, ciprofloxacin, levofloxacin and moxifloxacin for adverse reactions. The rates of adverse events are similar for quinolones and other antibacterial agents. However, quinolone therapy can be associated with specific risks, which must be… Expand
Appropriate use of fluoroquinolones in children.
TLDR
The use of FQs should be limited to selected respiratory infections, exacerbation of lung disease in cystic fibrosis, central nervous system infections, enteric infections, febrile neutropenia, as well as serious infections attributable to FQ-susceptible pathogen(s) in children with life-threatening allergies to alternative agents. Expand
Safety issues and drug–drug interactions with commonly used quinolones
TLDR
Although several adverse events have been associated with their use, taking into consideration risk factors, contraindications and potential drug–drug interactions can drastically reduce the respective risks. Expand
Safety considerations of current drug treatment strategies for nosocomial pneumonia
TLDR
The safety profiles of the most common antimicrobials for treating nosocomial pneumonia are analyzed, and linezolid seems to be the superior option for treating methicillin-resistant Staphylococcus aureus. Expand
Preserving the efficacy of front-line fluoroquinolones through selective use to optimise clinical outcomes.
  • H. Lode
  • Medicine
  • International journal of antimicrobial agents
  • 2014
TLDR
To preserve the potential of FQs and to minimise the risk of resistance selection, agents with the highest in vitro activity and supportive pharmacokinetic/pharmacodynamic profiles should be used first-line, as appropriate for local guidelines and prescribing information. Expand
Risks associated with the use of fluoroquinolones.
  • M. Delaney
  • Medicine
  • British journal of hospital medicine
  • 2018
TLDR
Patients who take a fluoroquinolone have an increased risk of developing tendinopathy, peripheral neuropathy, and aortic aneurysm or dissection and should consider the risk of these potential complications before using these medications. Expand
Systemic Quinolones and Risk of Acute Liver Failure II: Systematic Review of Clinical Trials
Background: Quinolones are a class with four generations of synthetic antibiotics characterized by a unique mechanism of action, broad spectrum, potent pharmacologic properties and reasonable safetyExpand
Adverse Effects of Fluoroquinolones: A Retrospective Cohort Study in a South Indian Tertiary Healthcare Facility
TLDR
A harmful association between FQ use and the development of ADRs is concluded, and FQs are not safe compared to other antibiotics, Hence, the use of F Qs should be limited to the conditions where no other alternatives are available. Expand
Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: A systematic review and meta-analysis of randomized controlled trials.
TLDR
FQs are associated with more CNS- and GI-related AEs compared with other types of antimicrobial, and this information is relevant to support decision making in relation to antimicrobial prescribing. Expand
Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis
TLDR
Hopes that levofloxacin was superior to ciprofloxacins for treatment of E. coli-induced chronic bacterial prostatitis (CBP) were raised and it required a further study to prove it, but the 2 drugs were comparable and both safe for clinical use. Expand
Insights on fluoroquinolones in cancer therapy: chemistry and recent developments
Abstract Cancer is a very risky life-threatening disease having most formidable afflictions in the world. Several anticancer agents are commercially accessible, however, the emergence of acquiredExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 62 REFERENCES
Safety Considerations of Fluoroquinolones in the Elderly
TLDR
Overall, the specific adverse-effect profile of quinolones must be considered when they are chosen for treatment of bacterial infections because of physiological changes in renal function and when certain co-morbidities are present, some special considerations are necessary when elderly patients are treated with these drugs. Expand
Safety Profile of the Fluoroquinolones
TLDR
Overall, it appears that levofloxacin is relatively well tolerated, with low rates of clinically important adverse events such as CNS toxicity, cardiovascular toxicity and dysglycaemia. Expand
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
TLDR
Only life-threatening infections for which other antimicrobials cannot be used are possible indications for quinolones in children, for example the use of ciprofloxacin in cystic fibrosis patients with a bronchopulmonary exacerbation, chronic suppurative otitis media caused by Pseudomonas sp. Expand
Will Fluoroquinolones Ever Be Recommended for Common Infections in Children?
  • U. Schaad
  • Medicine
  • The Pediatric infectious disease journal
  • 2007
TLDR
Overall, fluoroquinolones are generally well tolerated; the most frequent adverse events during treatment are gastrointestinal disturbances, reactions of the central nervous system, and skin reactions. Expand
Clinical toxicological aspects of fluoroquinolones.
TLDR
Overall, quinolones are as well tolerated as most other anti-microbial agents, however, their specific toxic potentials have to be considered when they are chosen for treatment of bacterial infections. Expand
Antimicrobial safety: focus on fluoroquinolones.
  • R. Owens, P. Ambrose
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2005
TLDR
The currently marketed quinolones are well tolerated, with safety profiles similar to those of other antimicrobial classes, although adverse effects are unusual, some, including tendinitis and CNS-related effects, are more common with quInolones than with other antimacterial classes. Expand
Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections.
  • H. Lode
  • Medicine
  • The American journal of medicine
  • 2010
TLDR
Medically significant AEs of agents included in the major antimicrobial classes--AEs that may be underappreciated by general practitioners are reviewed--considerable attention is devoted to the fluoroquinolone agents. Expand
Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin
TLDR
The data show that using moxifloxacin, in its accepted indications and following the corresponding guidelines, should not be associated with an excessive incidence of drug-related adverse reactions, provided the clinician takes care in identifying patients with known risk factors and pays due attention to the contraindications and warnings mentioned in the labelling. Expand
Effect of Combined Fluoroquinolone and Azole Use on QT Prolongation in Hematology Patients
TLDR
Combination therapy with fluoroquinolone and azole antifungals is associated with increased QTc from baseline in hospitalized patients with hematologic malignancies, warranting close monitoring and risk factor modification to prevent the possibility of furtherQTc prolongation and risk of TdP. Expand
Hepatic safety of antibiotics used in primary care
TLDR
Patients at risk are mainly those with previous experience of hepatotoxic reaction to antibiotics, the aged or those with impaired hepatic function in the absence of close monitoring, making it important to carefully balance potential risks with expected benefits in primary care. Expand
...
1
2
3
4
5
...